| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3397 | Mk-7725 | Novel bombesin receptor subtype-3 (BRS-3) modulator |
|
| DCC3398 | Mk-8245 Analog | Novel liver-targeting inhibitor of stearoyl-CoA desaturase (SCD) |
|
| DCC3399 | Mk-8666 Tromethamine | Novel agonist of G-protein coupled receptor 40 (GPR40) |
|
| DCC3400 | Mk-8970 | Prodrug of raltegravir with enhanced colonic absorption |
|
| DCC3401 | Mkk3/6-in-6 | Novel potent and selective MKK3/6 inhibitor |
|
| DCC3402 | Mkp5-in-1 | Novel highly specific, potent, orally bioavailable MKP5 inhibitor |
|
| DCC3403 | Km04794 | Novel endoplasmic reticulum proteostasis modulator, enhancing insulin production in pancreatic β cells, inhibiting the UPR, alleviating ER stress and protein aggregation, improving intracellular insulin levels and insulin secretion |
|
| DCC3404 | ml312 | Novel Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake |
|
| DCC3405 | Mlck Inhibitor Peptide-18 | Selective inhibitor of Myosin Light Chain Kinase (MLCK) |
|
| DCC3406 | Mln-0415 | Novel IKK2 inhibitor, decreasing NF-κB activation and down-regulating the expression of a number of inflammatory proteins |
|
| DCC3407 | Mln944 | Novel potent DNA binding agent, stabilizing topoisomerase-dependent cleavage, demonstrating exceptional efficacy against a number of murine and human tumor models |
|
| DCC3408 | Mln-977 | Second generation 5-LO inhibitor, blocking the production of leukotrienes |
|
| DCC3409 | Mls000099089 | Novel selective and potent inhibitor of recombinant h12/15-LOX and cellular mouse 12/15-LOX (m12/15-LOX) |
|
| DCC3410 | Mls000536924 | Potent and selective competitive inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2) |
|
| DCC3411 | Mls000545091 | Potent and selective mixed-type inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2) |
|
| DCC3412 | Mls000733230 | Novel potent inhibitor of EBOV infection |
|
| DCC3413 | Mls001158554 | Novel Inhibitor of Human Cytomegalovirus |
|
| DCC3414 | Mls-2064 | Potent inhibitor of STAT3 and Akt signaling |
|
| DCC3415 | Mls-2384 | Novel dual JAK/Src kinase inhibitor, suppressing growth of diverse cancer cells |
|
| DCC3416 | Mls8091 | Novel inhibitor of human cytomegalovirus (HCMV) infection |
|
| DCC3417 | Ml-sa3 | Potent agonist of TRPML channels specifically activating lysosomal ML1 currents |
|
| DCC3418 | Mlt-695 | Novel potent and selective MALT-1 protease inhibitor, showing improved solubility and permeability in comparison with MLT-748 |
|
| DCC3419 | Mmg-0358 | Novel potent IDO1 inhibitor, showing low cytotoxicity and higher selectivity for IDO1 over TDO enzyme |
|
| DCC3420 | Mmh371 | Novel potent and selective HDAC8 inhibitor |
|
| DCC3421 | Mmh409 | Novel potent and selective HDAC8 inhibitor |
|
| DCC3422 | Mmh410 | Novel potent and selective HDAC8 inhibitor |
|
| DCC3423 | Mmp13-in-t26c | Novel highly potent and selective MMP13 inhibitor |
|
| DCC3424 | M-mpep | Negative allosteric modulator (NAM) ligand for the mGlu5 receptor |
|
| DCC3425 | Mmpl3-in-e11 | Novel Mmpl3 inhibitor, indirectly blocking translocation of Trehalose Monomycolates across the IM |
|
| DCC3426 | Mms-350 | Highly water-soluble antifibrotic agent, reducing the profibrotic phenotype induced in vitro in primary human fibroblasts and ameliorating bleomycin-induced pulmonary fibrosis in vivo |
|
